s6y

Motif Bio plc

CIK
1674657
Industry
Pharmaceutical Preparations

Ownership 15

  1. SC 13D/A Major Shareholders
  2. SC 13D/A Major Shareholders
  3. SC 13D/A Major Shareholders
  4. SC 13G/A Major Shareholders
  5. SC 13D Major Shareholders
  6. SC 13G Major Shareholders
  7. SC 13G Major Shareholders
  8. SC 13D Major Shareholders
  9. SC 13G/A Major Shareholders
  10. SC 13G Major Shareholders

All 15 ownership filings

Prospectus 9

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  3. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  4. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  5. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  6. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  7. DRSLTR Correspondence Related to Draft Registration Statement
  8. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  9. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Other 139

  1. 15-12B Notice of termination of registration of a class of securities under Section 12(b)
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. EFFECT Notice of Effectiveness
  6. EFFECT Notice of Effectiveness
  7. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  8. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  9. 25 Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange
  10. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

All 139 other filings